Dear Editor,
The case report, 'Infected primary hydatid cyst located in Sartorius muscle' makes an interesting reading. [1] The photographs are good. It is a rare fi nding as stated by the authors since contractility and high lactic acid content of muscle do not allow the larvae to survive in muscle. Moreover, there are effective hepatic and pulmonary barriers. Predominant localization in the muscles of lower limb could be explained by the volume of muscle mass and rich blood supply. [2] However, there are few suggestions and details that need to be addressed.
The fi rst line of introduction states it to be a protozoan infestation. Echinococcus granulosus is a helminth, metazoan and cestode. The cyst was infected. Authors have not mentioned the culture report and names of the preoperative antimicrobials used for two weeks. As clinical microbiologists, we are interested.
A wet mount microscopy of the centrifuged deposit of cyst fl uid post surgery and examination of hydatid sand could have revealed the protoscolices and hooklets. It is simple and could have been done along with the histopathology. Hydatid sand is so-called because of the gritty feeling it gives when a drop of hydatid fl uid is rubbed between two slides. [3] Eosin stain of cyst fl uid can differentiate the dead protoscolices which take the stain from live ones which remain unstained. [4] The fi ndings in images need arrows to point out the exact location. They are radiological and imaging diagnosis, diffi cult to decipher for a microbiologist. The patient's association with live stock, sheep and cattle is shown but there is no mention of dogs. Canines are the optimum defi nitive host of hydatid sand, and dog faeces containing the eggs are the common source of infection. The magnitude of the problem is clear by the fact that World Health Organization included 
Need of microbiological investigations in the case of infected hydatid cyst

Bacillus cereus bacteraemia in a patient of acute myeloid leukaemia
Dear Editor, Immunocompromised patients are at high risk for acquiring infections. With the advances in microbiology, better diagnosis and treatment options are available. The empiric therapy in the febrile neutropenic patient is challenging and depends on the susceptibility patterns of organisms specifi c to that hospital. The correct identifi cation of the organism becomes imperative to guide the therapy in these patients. In addition to opportunistic pathogens, even organisms which are part of our normal fl ora also cause infections in these patients. We report here a case of bacteraemia with Bacillus cereus.
A 24-year-old female, who was undergoing chemotherapy for acute myeloid leukaemia (AML), was admitted in our ICU with febrile episodes from one
